Onconetix
Stock Forecast, Prediction & Price Target
Onconetix Financial Estimates
Onconetix Revenue Estimates
Onconetix EBITDA Estimates
Onconetix Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $58.46K 0% | Avg: $58.46K Low: $58.46K High: $58.46K avg. 0% | Avg: $58.46K Low: $58.46K High: $58.46K avg. 0% | Avg: $58.46K Low: $58.46K High: $58.46K avg. 0% | |
Net Income
% change YoY
| $-3.41M N/A | $-13.41M -292.69% | $-37.40M -178.76% | Avg: $-16.94M Low: $-16.94M High: $-16.94M avg. 54.71% | Avg: $-20.19M Low: $-20.19M High: $-20.19M avg. -19.19% | Avg: $-21.56M Low: $-21.56M High: $-21.56M avg. -6.77% | |
EBITDA
% change YoY
| $-3.41M N/A | $-13.53M -296.66% | $-36.70M -171.18% | Avg: $35.07K Low: $35.07K High: $35.07K avg. 100.09% | Avg: $35.07K Low: $35.07K High: $35.07K avg. 0% | Avg: $35.07K Low: $35.07K High: $35.07K avg. 0% | |
EPS
% change YoY
| -$0.31 N/A | -$1.09 -251.61% | -$2.19 -100.91% | Avg: -$0.99 Low: -$0.99 High: -$0.99 avg. 54.79% | Avg: -$1.18 Low: -$1.18 High: -$1.18 avg. -19.19% | Avg: -$1.26 Low: -$1.26 High: -$1.26 avg. -6.77% | |
Operating Expenses
% change YoY
| $3.41M N/A | $13.48M 294.49% | $33.72M 150.13% | Avg: $2.60M Low: $2.60M High: $2.60M avg. -92.27% | Avg: $2.60M Low: $2.60M High: $2.60M avg. 0% | Avg: $2.60M Low: $2.60M High: $2.60M avg. 0% | |
FAQ
What is Onconetix stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.58% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is -16.94M, average is -16.94M and high is -16.94M.
What is Onconetix stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is $58.46K, average is $58.46K and high is $58.46K.
What is Onconetix stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 9.60% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.99, average is -$0.99 and high is $-0.99.